Bacillus coagulans BCP92™

Bacillus coagulans BCP92™

Products
Bacillus coagulans BCP92™
Bacillus coagulans BCP92™

Information

Bacillus coagulans BCP92™ is a clinically validated, spore-forming probiotic strain for high stability, efficacy, and performance. It withstands extreme processing conditions including heat, acidity, and bile exposure, ensuring optimal survival and delivery to the gut. Scientifically and clinically proven, it supports gastrointestinal health, helps manage Irritable Bowel Syndrome (IBS), reduces diarrhea, and supports the gut-brain axis, contributing to improved mood and reduced symptoms of anxiety and depression. The strain demonstrates excellent compatibility across a diverse applications, including beverages, baked goods, and functional foods. Manufactured in an FSSC 22000 certified GMP facility, it is GRAS approved, non-animal origin, and Kosher and Halal certified. Available in multiple potencies and customizable blends, BCP92™ enables flexible formulation with extended shelf stability and consistent performance.
Health & Wellness Areas
Digestive HealthImmune Support
Ingredients
‎‎ ‎ - Bacillus coagulans
Delivery Formats
Powders
Certifications
Allergen-freeGluten-freeHalalHealth & Safety (GMP, HACCP and Equivalents)KosherNon-GMOVeganVegetarianOther Certifications
Pellucid lifesciences pvt ltd3K244Pellucid Lifesciences Private Limited is a fermentation-based biotechnology company founded in 2013 and located in Chhatral, Gujarat, India. Established with a vision to become a global leader in the manufacturing and marketing of probiotics, Pellucid focuses on spore-forming probiotics and delivers clinically backed, shelf-stable solutions that overcome traditional limitations of viability and scalability. With proprietary strains like BCP92™ and strong expertise in spray drying and formulation, the company enables brands to create differentiated, high-efficacy products across gut health, immunity, and beyond. The company operates a state-of-the-art fermentation facility with an R&D centre, established in 2016, supported by an experienced team specializing in microbiology, process development, and quality management. Pellucid offers a comprehensive portfolio of high-quality probiotic strains for a wide range of applications, including dietary supplements, nutraceuticals, and food and beverage formulations. Key strains include: Bacillus coagulans BCP92™ – Clinically proven and approved as GRAS (Generally Recognized as Safe) by the USFDA Bacillus clausii PBC429™- Clinically safe Bacillus subtilis BSP110™- Clinically safe These strains, along with others in Pellucid’s portfolio, offer high efficacy, stability, and versatility across various product formats. In addition to supplying individual strains and customized blends, Pellucid provides finished dosage forms including capsules, tablets, sachets, and gummies, along with contract manufacturing and white-label solutions for scalable global production. Quality and compliance are at the core of Pellucid’s operations. The company adheres to stringent international standards and holds multiple certifications, including. cGMP HACCP FSSAI FSSC 22000 v5 ISO 22000:2005 ISO/TS 22002-1:2009 HALAL Kosher (Star-K) Health Canada (NPN Approved)- Product License for Bacillus coagulans Driven by strong scientific research and customer-centric innovation, Pellucid Lifesciences continues to advance the probiotic industry by delivering world-class solutions tailored to evolving market needs, paving the way for sustainable growth and a healthier future.

Join the event!

See all the content and easy-to-use features by logging in or registering!